Study on preparation and lipid-lowering activity of a compoud based on "Cymbopogon flexuosus, Salvia miltiorrhiza, Panax ginseng and Pueraria lobata" active components

• Authors: Shaoji Lu , Jiancheng Chen , Jianping Yong , Zhihuang Guo , Jialiang Zhou , Ji Tai
• Languages of publication: EN

Abstracts

EN

Objective: to prepare an active compound from the extracts of four traditional Chinese medicines that can reduce blood lipids. Methods: In this study, the active components were respectively extracted from four Chinese herbal medicines, namely, "Cymbopogon flexuosus", "Salvia miltiorrhiza", "Panax ginseng" and "Pueraria lobata", and then the active components were mixed in different proportions to prepare a compound. Subsequently, the in vivo lipid-lowering effects were investigated, and the results showed that the compound prepared in this study has the efficacy of lowering blood lipids. Conclusion: The "compound" prepared in this study can be developed as a functional food or beverage with auxiliary lipid-lowering efficacy.

Keywords

EN

Cyanococcus aurantium; Panax ginseng; Pueraria lobata; Salvia miltiorrhiza; active components; compound; extractions; hypolipidemic

Discipline

• BIOTECHNOLOGY: BIOTECHNOLOGY

• Publisher: Scientific Publishing House „DARWIN”
• Journal: World News of Natural Sciences
• Year: 2024
• Volume: 55
• Pages: 16-24

Contributors

author

Shaoji Lu

• Xiamen Tasman Bio-Tech Research Institute, Xiamen, Fujian, China

author

Jiancheng Chen

• Xiamen Tasman Bio-Tech Research Institute, Xiamen, Fujian, China

author

Jianping Yong

• Xiamen Institute of Rare-earth Materials, Chinese Academy of Sciences, Xiamen, Fujian, China

author

Zhihuang Guo

• Xiamen Tasman Bio-Tech Research Institute, Xiamen, Fujian, China

author

Jialiang Zhou

• Xiamen Tasman Bio-Tech Research Institute, Xiamen, Fujian, China

author

Ji Tai

• Xiamen Tasman Bio-Tech Research Institute, Xiamen, Fujian, China

References

• [1] Wang Zengwu, Liu Jing, Li Jianjun, Wu Naqiong, Lu Guoping, Chen Zhenyue, Zhao Dong, Zhao Shuiping, Gao Runlin, Guo Yuanlin, Peng Daoquan, Yan Shengkai. Chinese Blood Lipid Management Guidelines. Chinese Journal of Circulation, 2023, 38 (3): 237-271
• [2] Luo Xiaowei, Feng Hang, Deng Qiongying, Gong Jichun, Gong Jiangu, Xu Lin. Correlation between body composition and blood lipids and blood uric acid in the Maonan ethnic group in Guangxi. Acta Anatomy Sinica, 2022, 53(1): 114-119
• [3] Lu Wenxuan, Fan Sijia, Li Wenyao, Yu Jingwen, Chen Lijuan, Deng Yue. Effect of Shenhong Tongluo Granules on cell apoptosis in atherosclerotic plaques in ApoE~(-/-) mice and its anti-atherogenic effects Mechanism of similar hardening. Journal of Jilin University (Medical Edition), 2016, 42(5): 882-886
• [4] Yang Yumin, Yao Jiarui. New progress and treatment monitoring of blood lipid-regulating drugs. Chinese Hospital Drug Evaluation and Analysis, 2021, 21(6):764-768
• [5] He Mengjie, Wang Fei, Wang Huafei, Gu Qianlan, Yin Ying. Clinical pharmacists participate in consultation on the use of hepatoprotective drugs in obstetric patients with abnormal liver function and analysis of typical cases. Chinese Pharmaceutical Industry, 2020, 29(24): 44-47
• [6] Liu Jing, Sheng Kai, Guan Feng, Luan Ning, Wang Rong, Wang Yanhong. Analysis of the medication rules of health food prescriptions with hypolipidemia function based on data mining method. Chinese Contemporary Medicine, 2022, 29(13): 14-19
• [7] Liu Jing, Sheng Kai, Guan Feng, Luan Ning, Wang Rong, Wang Yanhong.Analysis of the medication rules of health food prescriptions with hypolipidemia function based on data mining method. Chinese Contemporary Medicine, 2022, 29(13): 14-19
• [8] Wang Zengwu, Liu Jing, Li Jianjun, Wu Naqiong, Lu Guoping, Chen Zhenyue, Zhao Dong, Zhao Shuiping, Gao Runlin, Guo Yuanlin, Peng Daoquan, Yan Shengkai. Chinese Blood Lipid Management Guidelines. Chinese Journal of Circulation, 2023, 38(3), 237-271
• [9] Tang Mei, Zhao Lichun, Hu Zhiyi, et al. Research progress on the chemical components and pharmacological effects of Qingqianliu. International Journal of Pharmaceutical Research, 2017, 44(9): 851-859
• [10] Wu Zhihuan, Cao Xiaohan, Cao Dandan.Effect of Panax Salviae Miltiorrhiza Tablets on blood lipid levels in hyperlipidemic mice. Journal of Sichuan Agricultural University, 2021, 39(5): 660-665
• [11] Qiao Feng, Ge Lei, Fan Qiuling, Wei Zhenhua, Yu Tengfei.Study on the hypoglycemic and blood lipid-lowering effects of Qingqianliu extract combined with resistant dextrin. Chinese Food Additives, 2019, 30(9): 82-86
• [12] Liu Qing, Song Jiangang, Lu Rong, Li Yuanxia.Regulatory effects of flavonoids from Scutellaria baicalensis on blood sugar, blood lipids, and immune function in juvenile immunocompromised and obese rats. Guangxi Medicine, 2021, 43(10): 1209-1214
• [13] Huo Su, Cui Herong, Tian Xuehao, Zheng Juan, Jiang Wenyan, Dai Ziqi, Gao Mengyi, Xiang Jiawei, Chen Kedian, Wu Qianwen, Wang Penglong, Ma Tao, Lei Haimin. Structure-activity relationship and synergistic effect of components of Salvia miltiorrhiza that inhibit platelet aggregation. Northwest Pharmaceutical Journal, 2021, 36(1): 95-100
• [14] Wang Zhi, Hou Liqiang, Wang Shuang, Gao Fei. Research on the hypolipidemic effect and mechanism of compound Danshen Jiangzhiyin. Chinese Journal of Traditional Chinese Medicine, 2013, 31(12): 2659-2661
• [15] Ju Naixiang, Sun Jing.Research progress on the pharmacological effects of Panax notoginseng. Northern Pharmacy, 2014, (11): 90-91
• [16] Ma Peizhi, Chen Jinxiu.Effects of total flavonoids from Pueraria lobata on metabolic indicators and pathological morphology of liver tissue in rats with hyperlipidemia. Chinese Journal of Gerontology, 2021, 41(12): 2626-2629

• Document Type: article